The Pharmacy and Poisons Board (PPB) has issued a stern warning to health stakeholders against trading, importing, or handling unregistered pharmaceutical products in Kenya.
In a statement on Saturday, January 18, the PPB specifically cautioned against products referencing the Indian Pharmacopeia (IP). "All stakeholders are hereby directed to cease and desist from trading, importing, or handling any unregistered products and ensure that all pharmaceutical products in their possession are duly registered and approved by the Pharmacy and Poisons Board," the statement read.
The Board warned that noncompliance with this directive would result in the revocation of licenses and the seizure of products.
The Indian Pharmacopeia is a set of standards for drugs and medicines manufactured, sold, and consumed in India. .Keep ReadingKenya recalls Benylin cough syrup over safety concernsBe wary of fake cancer drug in the market, Poisons Board warnsPharmacy and Poisons Board warns of counterfeit diabetes drug in the marketPharmacy Board recalls Allied Limited's nasal drops, EfinoxHowever, the PPB clarified that these standards are not recognised under Kenya's drug registration requirements, rendering products citing the IP non-compliant.
